D. Boral Capital Maintains Buy on Tevogen Bio Holdings, Lowers Price Target to $2
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy and lowers the price target from $5 to $2.
D. Boral Capital analyst Jason Kolbert maintains Tevogen Bio Holdings (NASDAQ:TVGN) with a Buy and lowers the price target from $5 to $2.